Effects of Prolonged High Disease Activity on Damage Accumulation and Clinical Outcomes in Pediatric Systemic Lupus Erythematosus
-
By
-
Ninlapat Jidmahawong
-
Butsabong Lerkvaleekul
-
Kwanchai Pirojsakul
-
Soamarat Vilaiyuk
-
June 18, 2026
Clinical Scorecard: Effects of Prolonged High Disease Activity on Damage Accumulation and Clinical Outcomes in Pediatric Systemic Lupus Erythematosus
At a Glance
| Category | Detail |
| Condition | |
| Key Mechanisms | Cumulative high disease activity (HDAS) associated with damage accrual (source needed). |
| Target Population | |
| Care Setting | |
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
- M
- u
- l
- t
- i
- d
- i
- s
- c
- i
- p
- l
- i
- n
- a
- r
- y
-
- c
- a
- r
- e
-
- a
- p
- p
- r
- o
- a
- c
- h
-
- i
- n
- v
- o
- l
- v
- i
- n
- g
-
- p
- e
- d
- i
- a
- t
- r
- i
- c
-
- r
- h
- e
- u
- m
- a
- t
- o
- l
- o
- g
- i
- s
- t
- s
-
- a
- n
- d
-
- n
- e
- p
- h
- r
- o
- l
- o
- g
- i
- s
- t
- s
-
- (
- s
- o
- u
- r
- c
- e
-
- n
- e
- e
- d
- e
- d
- )
- .
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with HDAS require intensive immunosuppressive medications (source needed).
Clinical Best Practices
Related Resources & Content